Don't let that huge (headline) yoy revenue drop confuse you, the algos are reacting to that, it's an accounting thing. They raised 2022 guidance substantially and their bio-security division was raised to $310M... at a 41% margin. This thing should have strong support at $2.40ish _______________________ Full Year 2022 Guidance Ginkgo expects to add 55-60 new Cell Programs to the Foundry platform in 2022 Ginkgo further revised its expectation for Total revenue from $425 – $440 million to $460 – $480 million in 2022 Ginkgo revised its expectation for Foundry revenue to $150 – $170 million in 2022, which reflects our current assumptions and uncertainty regarding the timing of certain discrete milestone payments While Biosecurity remains an uncertain business, based on strong year-to-date performance Ginkgo now expects Biosecurity revenue in 2022 of at least $310 million -------------------- 280 block trades today. 6M shares. Always a good sign Edit That's almost a 10% increase in revenue guidance... with one quarter left?!! Business must be pretty damn strong. $2.57 now Stoney. Don't miss the boat.
Cathie Wood Keeps Buying Ginkgo Bioworks (DNA) Stock Wood keeps buying DNA stock despite it being down more than 60% so far this year Oct 6, 2022, 10:17 am EST Rare young Cathie Wood Photo: "Dreaming of Stoney". ©1988 Alien Museum of Art Cathie Wood can’t seem to get enough of Ginkgo Bioworks (NYSE:DNA). Running ARK Invest, Wood has acquired more than 250,000 shares of DNA stock. The Boston-based biotechnology company finished trading at $3.31 per share on Oct. 5. Wood has been buying DNA stock through her various exchange-traded funds (ETFs) which focus on companies engaged in disruptive technologies. Year-to-date (YTD), Wood’s flagship ARK Innovation ETF (NYSEARCA:ARKK) is down 58% and trading near $40 per share. Here’s what investors should know about Ginkgo and Wood’s share purchases moving forward. What’s Happening With DNA Stock? Wood’s interest in Ginkgo Bioworks comes after the company made a series of strategic acquisitions. On Oct. 4, Ginkgo announced that it was acquiring biotech company Circularis to help bolster its cell and gene-therapy capabilities. At the same time, Ginkgo also acquired Altar, a French biotech name that has developed a “proprietary adaptive evolution platform.” Financial terms for either of these deals were not disclosed. Founded in 2009 by several scientists at the Massachusetts Institute of Technology (MIT), Ginkgo is engaged in genetic engineering wtf:) that produces bacteria which can be used in industrial applications. The company has been valued at as much as $4.2 billion. However, DNA stock has declined 61% this year and fallen 69% since its market debut in 2021 via a reverse merger with a special purpose acquisition company (SPAC).
VP of Varonis Systems (VRNS) James O'Boyle purchased 60,000 shares of company stock at $16.72 per share for a total transaction amount of $1,003,200
Thinking Disney needs some PENN X ESPN love... Don't think PENN has any exposure to China.. but they owe $10 mil to this one guy... Penn Entertainment moves higher on speculation of activist after 13-F filing Nov. 14, 2022 9:52 AM ET PENN Entertainment, Inc. (PENN) Penn Entertainment (NASDAQ:PENN) rose 6.2% on some speculation of a potential activist investor after a Goldman Sachs 13-F filing. The disclosure that Goldman Sachs purchased 4.5 million shares in Q3, or about a 3% stake, could be a sign of an activist, Gordon Haskett highlighted in a note on Monday. The Goldman Sachs purchase may be noteworthy because prime brokerage sometimes acts as counterparties for activist swap positions. Penn Entertainment, whose shares have dropped 30% this year, reported Q3 results earlier this month.
Over it's 50 & 200 day<-------- Description PENN Entertainment, Inc., together with its subsidiaries, provides integrated entertainment, sports content, and casino gaming experiences in North America. The company operates through five segments: Northeast, South, West, Midwest, and Interactive. It operates 44 properties in 20 states; online sports betting in 13 jurisdictions; and iCasino in five under a portfolio of brands, including Hollywood Casino, L'Auberge, Barstool Sportsbook, and theScore Bet. The company was formerly known as Penn National Gaming, Inc. and changed its name to PENN Entertainment, Inc. in August 2022. PENN Entertainment, Inc. was founded in 1972 and is based in Wyomissing, Pennsylvania.
A ways back PENN bought Barstool ansd has done nothing with it... August 19, 2022 Barstool Sports to be fully acquired by Penn Entertainment in $387 million deal The casino and racetrack operator bought a 36% stake in the sports media company in 2020. Now, it is purchasing the rest of its shares from Alberto Barstool Sports, founded by Dave Portnoy, above, is being fully acquired by Penn Entertainment, which first bought a stake in the sports media company in 2020. The company's Barstool Sports app allows online sports betting in 12 states, including Pennsylvania and New Jersey. Penn Entertainment is taking full control of Barstool Sports as part of a $387 million deal. Penn Entertainment, which rebranded from Penn National Gaming earlier this month, purchased 36% of the digital media company in 2020 for $163 million. Penn has since exercised a provision that allows it to purchase Barstool's remaining shares through a two-step process. To complete the transaction, the Berks County-based casino and race track operator must pay $62 million to increase its stake to 50% and then another $325 million for the rest of the shares. The sale is expected to be completed by February 2023, Fox Business reported. //////// ESPN needs gambling.... Barstool is collecting mothballs./. Why not do something big here??
Chart Events Bullishpattern detected Price Crosses Moving Average... $37.60 <------------------------ THE SAVANT LIKES PENN